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ABSTRACT 
 
 
Yunus Annayev: Characterization of a new circadian clock gene Gm129 
(Under the direction of Aziz Sancar)   
     Circadian clock is a 24hr rhythmicity that controls behavioral, metabolic events in most of the 
organisms. It has been reported that around 10% of all transcripts in mice show circadian 
expression pattern. The circadian clock is regulated by core clock which in most organisms is 
controlled by a transcription-translation feedback loop (TTFL). Transcriptional activators 
constitute positive arm of the TTFL and transcriptional repressors constitute the negative arm of 
the (TTFL).  
    In a ChIPseq analysis in mice liver we found that core clock genes bind strongly to the 
promoter of a previously uncharacterized gene called Gene Model 129 (Gm129). Gm129 
transcript and the protein show a very high amplitude oscillation in mouse liver. Given these core 
clock gene like characteristics of Gm129, I analyzed its function in the core clock and found that 
it interacts with BMAL1 and PER2. Additionally, Gm129 binds to BMAL1/DNA complex both 
in vitro and in vivo. In the reporter gene assay it inhibits CLOCK/BMAL1 induced transcription 
suggesting that it functions as a repressor. Gm129 knock-out mice show altered circadian 
transcription of clock genes and this effect is more dramatic when Gm129 mutation was 
combined with Cry1 mutation.      
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    Overall, I have demonstrated that Gm129 is novel circadian clock repressor. Characterization 
of Gm129 provides more insight on how the circadian clock machinery functions in mammalian 
organisms.   
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CHAPTER 1: INTRODUCTION 
 
 
Circadian Clock 
 
       The term “circadian” is derived from Latin words circa (about, approximate) and diem (day) 
and refers to a time period in an approximate length of the day. Circadian clocks are endogenous 
timekeeping systems that govern the daily cycles of behavior and physiology in a variety of 
organisms (2,3). The molecular clock that drives circadian expression of clock controlled genes 
(CCGs) has been well characterized in model organisms such as Neurospora crassa, Arabidopsis 
thaliana, Drosophila melanogaster, and Mus musculus.  
    Although core clock mechanisms in most organisms are conserved, the key players and 
functions of the genes has been diversified and became more complex from primitive organisms 
to mammals (4).   One of the first core clock genes discovered is Period (Per) in Drosophila (5). 
Genetic studies in mice lead to discovery of additional genes that function in the regulation of the 
circadian clock (6,7). Classical model of mammalian core clock involves CLOCK and BMAL1 
as transcription activators and Cryptochrome (CRY) and Period (PER) as transcription 
repressors. CLOCK and BMAL1 constitute the positive arm of the transcription-translation 
feedback loop (TTFL and CRY and PER constitute the negative arm of the transcription-
translation feedback loop (TTFL (Figure 1.1) (1). 
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   Each of the core clock genes are well characterized in mice. The effects of gene mutations on 
period length are analyzed by recording the wheel running activities of mice in which mice are 
kept in light/dark cycle for a certain period of time and then stitched to dark/dark cycle. Period 
length of wild-type mice in total darkness is about 23.8 hours.  Cry1 mutation in mice shortens 
the period by 1 hour and Cry2 mutation lengthens it by 1 hour. Cry1/Cry2 double knock-out 
mice are arrhythmic (8). Bmal1 knock-out mice are also arrhythmic (9). Clock knock-out mice 
show 0.5hr shorter periods (10) and Per2 knock-out mice are arrhythmic after several days in 
constant darkness (11). Table 1.1 summarizes the period changes in mice mutant to specific 
clock gene.  
Figure 1.1: Core clock model. CLOCK and BMAL1 function in the positive arm 
of the TTFL by activating circadian transcription through binding to the E-Box 
enhancer elements in the promoters of clock controlled genes. CRY and PER 
function in the negative arm of the TTFL and inhibit CLOCK/BMAL1 induced 
transcription (1). 
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Table 1.1 Effect of clock gene mutations on period lenght.  Summary of period changes in 
mice deficient of core clock genes or secondary clock regulators. n/d- not determined, DD- dark-
dark cycle. (Modified from (12) ).  
    
Gene Allele Mutant phenotypes in DD 
Bmal1 Bmal1−/− Arrhythmic 
Clock ClockΔ19/Δ19 4 h longer period/arrhythmic 
 Clock−/− 0.5 h shorter period 
Per1 Per1Brdm1 1 h shorter period 
 Per1ldc 0.5 h shorter period 
 Per1−/− 0.5 h shorter pd/arrhythmic 
Per2 Per2Brdm1 1.5 shorter pd/arrhythmic 
 Per2ldc Arrhythmic 
Per3 Per3−/− 0–0.5 h shorter period 
Cry1 Cry1−/−  1 h shorter period 
Cry2 Cry2−/−  1 h longer period 
Rev-erbα Rev-Erbα−/− 0.5 h shorter period 
  Disrupted photic entrainment 
Rorα Staggerer 0.5 h shorter period 
  Disrupted photic entrainment 
Rorβ Rorβ−/− 0.5 h longer period 
Rorγ Rorγ−/− Unknown 
NPAS2 NPAS2−/− 0.2 h shorter period 
Bmal2  n/d 
CK1ε CK1εtau c 0.4 h shorter period 
 CK1ε−/− 0.3 h longer period 
CK1δ Csnklδ−/+ 0.5 h shorter period 
DecI Dec1−/− No difference in period 
 Dec1−/− 0.15 h longer period 
 Sharp2−/− No difference in period 
Dec2 Sharp1−/− No difference in period 
Fbxl3 Fbxl3−/− 2–3 h longer period 
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   Since the establishment of core clock model, there were discoveries of other genes that play roles 
in the regulation of the circadian clock. Nuclear receptor proteins (Nr1d1, Nr1d2, and RORs (α, β, 
γ)) and D-box binding proteins (DBP and NFIL3) have been shown to function in the regulation 
of the circadian clock. Clock controlled genes have also been shown to be controlled by other 
additional response elements such as D-box (DBP response element TTATG(C/T)AA) and RRE 
(RevErbA response element, or ROR response element (RORE) (A/T)A(A/T)NT (A/G)GGTCA)) 
(13). Some of the core clock genes are regulated by these two regulatory sites. Per (1, 2, and 3), 
Cry1, Nr1d1, Nr1d2, Rorα, and Rorβ genes have D-boxes in their promoters. In contrast, Bmal1, 
Clock, Npas2, Cry1, NFIL3, and Rorc are regulated by RORE sites.  Figure 1.2 shows the most 
recent clock model in which the regulation of clock controlled genes with E-boxes, D-boxes and 
RORE sites are summarized. Nuclear receptors Nr1d1 and Nr1d2 (also called Rev-Erb α and β) 
act as repressors of clock controlled genes that have RORE sites in their promoters and Bmal. 
Opposed to Nr1d1 and Nr1d2, RORs (α,β,γ) activated the transcription of genes with RORE sites 
(14).  Latest promoter element that was characterized in clock controlled genes is he D-box. DBP, 
which itself is regulated by E-box promoter elements, acts as the activator of D-box genes which 
include Per genes. Repressor of D-box genes is NFIL3 (also known as E4BP4) which is regulated 
by the RORE in its promoter (13). Combination of these two and the classic E-box driven core 
clock mechanisms together with posttranslational modifications of core clock proteins regulate the 
circadian clock and achieve almost 24-hour periods in mice and other mammals.  
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Figure 1.2 Core clock model summarizing secondary loops of circadian clock regulation. 
Loop 1 involves classic core clock proteins that regulate clock controlled genes by binding to the 
E-boxes. Loop 2 involves nuclear receptor proteins that regulate core clock genes by binding to 
the RORE sites. Loop 3 involves D-box binding protein DBP which activate the transcription 
and NFIL3 which represses the transcription of clock controlled genes regulated by the D-box 
elements. (Adapted from (15) ).  
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     The master regulator of the circadian clock in mammals is located in suprachiasmatic nucleus 
(SCN). However, it has been shown that peripheral tissues such as liver (16) have their own 
circadian clocks indicating presence of cell-autonomous oscillators. Individual tissues and organs 
rely on signals from the master regulator (SCN) to be entrained with the surrounding 
environment. SCN receives photic information from retina and keeps other parts of the body 
entrained by means of neuronal signals, endocrine signals and body temperature fluctuations. 
Genome-wide transcriptome analysis found that between %2-%10 of genes in the peripheral 
tissues show circadian oscillation (17-20).  
    Most of the oscillating genes in peripheral tissues function in key pathways such as metabolic 
pathways, signaling pathways etc. (21).   Therefore, it is expected that the disruption of circadian 
rhythm can have serious consequences in the organism. One of the classic papers demonstrating 
a link between circadian clock disruption and health implications showed that there is increased 
risk of breast cancer in nurses working on rotating night shifts (22). In addition, circadian clock 
disruption has also been linked to sleep disorders. Familial advanced sleep-phase syndrome 
(FASPS) is a sleep disorder in which people have difficulty staying awake until desired time and 
staying asleep until desired time. S662G mutation in the Per2 gene which increases PER2 
turnover and leads to shorter periods was shown to be the primary cause of FASPS (23). Another 
mutation in core clock gene Clock (CLOCKΔ19) was shown to make mice obese as a results of 
hypoglycemia and hypoinsulinaemia since key enzymes in the metabolic pathways are controlled 
by the circadian clock (24).  There are some studies linking core clock gene mutation to 
predisposition to cancer but that area remains controversial because of several conflicting studies 
(25,26). Bmal1 knock-out mice were shown to age early and the reasoning was the regulatory 
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pathways that Bmal1 is associated with such as the regulation of reactive oxygen species (ROS) 
homeostasis (27).  
   Overall, circadian clock is an important aspect of daily life in almost all organisms and its 
disruption has some serious implications for the organisms’ physiology and well-being. There 
are still some unanswered questions regarding how each of the core clock genes function. It is 
possible that there remains more genes that play a role in circadian clock regulation to be 
discovered. This thesis is based on the work that characterizes a novel circadian clock gene 
called Gene Model 129 (Gm129). We show that Gm129 functions as a repressor in the negative 
arm of the TTFL.   
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CHAPTER 2: 
Gene Model 129 (Gm129) Encodes a Novel Transcriptional Repressor that Modulates 
Circadian Gene Expression 
 
 
Summary 
 
    The mammalian circadian clock is a molecular oscillator composed of a feedback loop that 
involves transcriptional activators CLOCK and BMAL1, and repressors Cryptochrome (CRY) and 
Period (PER). Here we show that a direct CLOCK-BMAL1 target gene, Gm129, is a novel 
regulator of the feedback loop. ChIP analysis revealed that the CLOCK:BMAL1:CRY1 complex 
strongly occupies the promoter region of Gm129. Both mRNA and protein levels of GM129 
exhibit high amplitude circadian oscillations in mouse liver, and Gm129 gene encodes a nuclear-
localized protein that directly interacts with BMAL1 and represses CLOCK:BMAL1 activity. In 
vitro and in vivo protein-DNA interaction results demonstrate that, like CRY1, GM129 functions 
as a repressor by binding to the CLOCK:BMAL1 complex on DNA. Although Gm129-/- or Cry1-
/- Gm129-/- mice retain a robust circadian rhythm, the peaks of Nr1d1 and Dbp mRNAs in liver 
exhibit significant phase delay compared to control. Our results suggest that, in addition to CRYs 
and PERs, GM129 protein contributes to the transcriptional feedback loop by modulating 
CLOCK:BMAL1 activity as a transcriptional repressor. 
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INTRODUCTION 
 
    Circadian clocks are endogenous timekeeping systems that govern the daily cycles of behavior 
and physiology in a variety of organisms (2,3). In mammals, the 24-hour circadian oscillator 
operates as a transcription-translation feedback loop (TTFL) involving both positive 
(transcriptional activators) and negative (transcriptional repressors) components. The 
transcriptional activators are CLOCK/NPAS2 and BMAL1, whereas Cryptochrome (CRY1 and 
CRY2), and Period (PER1 and PER2) act as transcriptional repressors. In the TTFL model, 
CLOCK:BMAL1 heterodimers bind to the promoter region of Per and Cry genes through E-box 
DNA regulatory sites and activate transcription. Upon transcriptional activation, gradually 
accumulated CRY and PER proteins abrogate their own transcription by repressing 
CLOCK:BMAL1’s activity (28,29). This feedback loop repeats every ~24 hours and results in 
rhythmic activities of the CLOCK-BMAL1 complex. Besides the promoters of Cry and Per genes, 
CLOCK:BMAL1 also binds to E-box elements in the promoter regions of thousands of clock-
controlled genes, including transcription factors, such as the nuclear receptor Rev-erb alpha 
(Nr1d1), and the PAR domain bZIP transcription factors Dbp (21). These CLOCK:BMAL1 
controlled transcription factors also exhibit high amplitude oscillation at the protein level in 
tissues. Thus, the CLOCK:BMAL1 complex and clock controlled transcription factors drive 
massive transcriptional oscillation in various tissues in mammals (18). 
    As described above, the interactions between CLOCK:BMAL1 and E-box elements play a 
major role in circadian transcriptional regulation. To understand the direct targets of the 
CLOCK:BMAL1 complex and the molecular architecture of the circadian timing system, several 
studies have been conducted to identify the CLOCK:BMAL1 DNA binding sites in vivo using 
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ChIP-Seq analysis (30,31). It was reported that, in liver, BMAL1 rhythmically bound to ~2000 
genomic targets (31). Based on these ChIP-Seq results, direct CLOCK:BMAL1 target genes were 
predicted and were ranked according to binding strength. Interestingly, among the target genes 
with highest BMAL1 chromatin binding strength, most of them are well-studied circadian genes. 
The top 10 CLOCK:BMAL1 target genes include three core clock gene Per1, Per2, Cry2 (8,32); 
three nuclear receptors Rorc, Nr1d1 and Nr1d2 involved in the core clock regulation (33,34), and 
three PAR domain bZIP transcription factors Dbp, Hlf and Tef which function as key genes in the 
output pathways (35). Only one gene remains uncharacterized, which is gene model 129 (Gm129) 
that encodes a novel protein with no predicted functional domains. Gm129 is also implicated as a 
direct CLOCK:BMAL1 target gene based upon its strong transcriptional oscillation in liver in a 
additional independent BMAL1 ChIP-seq analysis using NIH3T3 and WI38 cell line (30).  
    Coincidently, a ChIP-seq and gene expression study in our group also found that Gm129 is a 
direct target gene of the BMAL1:CLOCK:CRY1 complex, and Gm129 exhibits high amplitude 
protein oscillation in mouse liver. These properties suggest that Gm129 might be an important 
factor in the molecular clock. Thus, we have conducted detailed molecular, biochemical and 
genetic analysis to characterize Gm129’s roles in circadian clock regulation. In this study, we 
demonstrate that GM129 can directly interact with core clock proteins BMAL1 and PER2. GM129 
also localizes in the nucleus and strongly represses CLOCK:BMAL1 transcriptional activity in a 
reporter gene assay. Additional in vitro and in vivo assays suggest that GM129 protein directly 
interacts with the CLOCK-BMAL1 complex on DNA. In mouse liver, the absence of Gm129 
extends the peak expression of Nr1d1 and Dbp. More importantly, in the Cry1-/- background, the 
Gm129 knockout causes a significant phase shift of Nr1d1 and Dbp gene expression. We conclude 
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that Gm129 functions as a novel transcriptional repressor in the mammalian clock transcription-
translation feedback loop. 
 
Results 
 
The Gm129 gene is a direct target of CLOCK:BMAL1:CRY1 and oscillates in mouse liver  
 
    Previously we reported that CRY1 binds to CLOCK:BMAL1 on DNA both by in vitro EMSA 
assay and in vivo ChIP assay in mouse fibroblasts (36). To systematically examine binding of the 
native CLOCK:BMAL1:CRY1 core clock complex to CCG (Clock controlled gene) promoters in 
mouse tissue, we conducted ChIP assays using liver to map the chromatin binding sites of CLOCK, 
BMAL1 and CRY1. As shown in Figure 2.1A, in agreement with a previously published report 
(37), both BMAL1 and CRY1 rhythmically bind to Dbp and Nr1d1 promoter and reach their peak 
affinities at ZT6-ZT10 (for BMAL1) and ZT20-ZT24 (for CRY1) in ChIP assays. To simplify the 
experiment design and achieve best signal-to-noise ratio for identifying chromatin binding sites of 
core clock protein complex, we conducted our CLOCK and BMAL1 ChIP-seq using liver 
harvested at ZT8 and CRY1 ChIP-seq with liver harvested at ZT20. Figures 2.1B and 2.1C show 
the representative samples of ChIP-seq data we obtained using anti-CLOCK, anti-BMAL1, and 
anti-CRY1 antibodies. As shown in Figure 2.1B, CLOCK, BMAL1 and CRY1 all bind to the 
promoters of the core clock repressive factors: Cry1, Cry2, Per1 and Per2. Besides these core 
components, these positive (CLOCK and BMAL1) and negative (CRY1) regulators also bind to 
the promoters of the secondary/consolidating loop component Rev-Erb alpha/Nr1d1 as well as to 
the promoter of the clock-controlled transcription factor Dbp1.  
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    Consistent with other published studies (30,31,38), our ChIP-seq results showed that the Gm129 
gene has high affinity binding sites for CLOCK, BMAL1 and CRY1 in its promoter region (Figure 
2.1C). To further characterize this binding, we carried out ChIP-PCR assays with livers harvested 
at different time points to examine circadian rhythmicity of binding of CLOCK:BMAL1:CRY1 
complex to the Gm129 promoter. Figure 2.1D shows ChIP-PCR data over the course of a diurnal 
cycle for the Gm129 gene. Clearly, both BMAL1 and CRY1 rhythmically occupy E-boxes in the 
Gm129 promoter with different binding phases.  
    It was also reported that Gm129 exhibits circadian gene expression in mouse liver (30). To 
confirm these results, time series quantitative PCR was conducted with mouse livers harvested 
over one diurnal cycle.  Indeed, Gm129 mRNA levels show very high amplitude (~17 fold 
difference between zenith and nadir) oscillation with a peak at ZT12 (Figure 2.2A). Because in 
some cases, a rhythmically expressed gene can produce a constitutively expressed protein (39), the 
GM129 protein level was also examined by time-series immunoblotting of mouse liver extracts 
made over a circadian cycle (constant dark). As shown in Figure 2.2B, GM129 protein also 
exhibits high amplitude oscillation in the mouse liver nucleus with a peak at CT12. Thus, all these 
results suggest that Gm129 is a direct target of CLOCK:BMAL1:CRY1 complex and encodes a 
protein with high amplitude circadian oscillation.  
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Figure 2.1: Gm129 is a direct target of the CLOCK: BMAL1: CRY complex. 
(A) Rhythmic Binding of BMAL1 (blue curve) and CRY1 (orange curve) to the Dbp and Nr1d1 
promoter region in mouse liver over one 12h light:12h dark cycle. Chromatin immunoprecipitation 
analysis was conducted using antibodies against BMAL1 and CRY1. Cross-linked chromatins 
14 
 
were prepared from mouse liver tissues taken at 4-h intervals in a 24- hour cycle. Error bars 
represent standard deviation of 3 biological repeats. 
(B) Highly overlapping CLOCK, BMAL1 and CRY1 binding to the Per1, Per2, Cry1, Nr1d1 and 
Dbp gene. Gene tracks represent binding of CLOCK (blue), BMAL1(green), and CRY1(red) to 
various genes. Gray rectangles highlight co-occupied sites. The scale of the y axis (peak height) is 
adjusted for individual traces for visual clarity. Beneath each set of gene tracks is a representation 
of the intron/exon structure. Black arrow indicates the orientation of transcription. 
(C) Binding of CLOCK:BMAL1:CRY1 complex to the promoter region of the Gm129 gene.  
(D) Rhythmic binding of BMAL1 (black bars) and CRY1 (dashed bars) to the Gm129 promoter 
region in mouse liver over one 12h light:12h dark cycle. Nuclear extracts were prepared from 
mouse liver tissues collected at 4-h intervals in a 24- hour cycle and subjected to chromatin 
immunoprecipitation analysis using antibodies against BMAL1 and CRY1. Error bars represent 
standard deviation of 3 biological repeats. 
 
 
 
 
 
 
 
 
 
 
 
 
 
15 
 
GM129 protein localizes in the nucleus and interacts with PER2 and BMAL1 
 
    GM129 is a 375-amino acid protein with no analogs in the mouse genome, and it has no known 
protein motifs or domains to guide for a potential functional assignment. Thus, we decided to 
determine its subcellular localization to obtain clues about its molecular functions. To this end, we 
constructed a GFP fusion construct of GM129 and transfected HEK293T cells with this plasmid. 
We found that the GFP-GM129 protein largely localizes in the nucleus (Figure 2.2C). In contrast, 
GFP alone exhibits both nuclear and cytoplasmic localization. Interestingly, the top 10 direct 
CLOCK:BMAL1 target genes with known function all encode nuclear proteins that function as 
either core clock components (PERs and CRYs) or circadian transcriptional factors that are 
responsible for output pathways (DBP, HLF, TEF, NR1D1 and NR1D2). Unlike circadian 
transcription factors in output pathways, core clock proteins normally interact with each other 
(40,41). Thus, to further clarify the function of GM129, we decided to test protein-protein 
interactions between GM129 and core clock proteins using the baculovirus expression system. As 
shown in Figure 2.3A, GM129 has a strong affinity to BMAL1 and PER2, but not CRY1. 
Additionally, GM129 binds to endogenous BMAL1 in an NIH3T3 cell line that stably expresses 
Flag-GM129 protein (Figure 2.3B). Hence, the nuclear localization and direct interaction with 
core clock proteins strongly support the hypothesis that GM129 is a novel circadian regulator.  
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Figure 2.2: GM129 is a nuclear protein and oscillates in mouse liver 
(A) Circadian oscillation of Gm129 mRNA in mouse liver. Mice were sacrificed at Zeitgeber times 
(ZT) 4, 8, 12, 16, 20 and 24/0 hours. The abundance of Gm129 mRNA was determined by 
quantitative RT-PCR and normalized to that of Gapdh. The maximal value was normalized to 1. 
Error bars represent standard deviation of 2 biological repeats. The 0/24 hour time point is plotted 
twice to emphasize the trend.  
(B) Oscillation of GM129 and core clock protein levels in liver nuclei. Mice were kept in constant 
dark for 24 hours following 12hrs dark /12hrs light cycles.  After 24 hours in the dark, nuclear 
extracts were prepared from livers collected at 0, 4, 8, 12, 16, and 20 hours in dim red light and 
GM129 was detected by western blots. The XPB protein was used as a loading control. The 
GM129 signal is marked by a red asterisk. Note there is a nonspecific antibody cross-reactive band 
above the GM129 signal. The blot is representative of two experiments.  
(C) Subcellular localization of GM129-EGFP fusion protein. HEK293T cells were transfected 
with plasmid DNA expressing GM129-EGFP protein or EGFP alone. 48 hours post transfection, 
cells were fixed and visualized by fluorescence microscopy (GFP) and DAPI staining. Nuclear 
localization was confirmed by merging the GFP signal with the DAPI signal. EGFP alone is a 
control that localizes to both cytoplasm and nucleus. Bar = 10 μm. 
17 
 
 
GM129 represses CLOCK and BMAL1 induced transcription 
 
    Although GM129 strongly binds to BMAL1 and PER2 protein, it was not known whether this 
interaction can regulate the activity of the core clock protein complex. Interestingly, like GM129, 
CRY1 also binds to BMAL1 and PER2 and functions as a strong repressor of CLOCK:BMAL1. 
Thus, we reasoned that GM129 might function as a transcriptional regulator by interacting with 
BMAL1. To investigate GM129 function, a luciferase reporter gene assay was conducted in 
HEK293T cells using a Per1::Luc reporter (40). Co-expression of CLOCK and BMAL1 generate 
>6 fold induction of Luciferase activity compared to expressing BMAL1 alone (Figure 2.3C). 
CRY1 is a positive control in this assay that efficiently represses CLOCK:BMAL1 activity. 
Importantly, the additional co-expression of either CRY1 or GM129 reduced the Luciferase 
activity to the basal level (Figure 2.3C).  As shown in Figure 2.3D, the repressor function of 
GM129 is also dose dependent, since as the amounts of Gm129 or Cry1 plasmids transfected were 
increased, there was increasing inhibition of CLOCK:BMAL1 activated transcription. In 
comparison with CRY1, it appears that GM129 is nearly equally efficient in repressing 
CLOCK:BMAL1 activity (Figure 2.3D). Together with nuclear localization and protein-protein 
interaction results, repression of CLOCK:BMAL1 activated transcription by GM129 suggests a 
role in the negative arm of the transcription-translation feedback loop (TTFL).  
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Figure 2.3: GM129 interacts with BMAL1 and PER2, and represses CLOCK/BMAL1 
activated transcription.  
(A) GM129 interacts with BMAL1 and PER2. Sf21 cells were co-infected with Flag-GM129 
baculovirus together with either PER2-Strep-His, BMAL1-His, or CRY1-His baculovirus. Cell 
extracts were prepared 48 hours after infection and subjected to immunoprecipitation using FLAG 
resin. Immunoprecipitates were analyzed by western blot.  
(B) GM129 interacts with endogenous BMAL1 in an NIH3T3 cell line stably expressing Flag-
GM129. Immunoprecipitates obtained with FLAG resin from whole cell lysates were probed by 
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immunoblotting. GM129 and BMAL1 were detected by anti-FLAG anti-BMAL1 antibody, 
respectively.  
(C) HEK293 cells were transiently transfected with 25 ng of Per1 luciferase reporter construct, 
2.5 ng of pBind (for normalization of transfection efficiency) and a total 250 ng of the indicated 
combinations of Clock, Bmal1, Gm129, and Cry1 expressing constructs together with pcDNA4. 
Cells were collected 48 h after transfection. Error bars represent standard deviation from 3 
experimental repeats.  
(D) Dose–response studies of inhibition of CLOCK-BMAL1 induced transcription by the GM129 
and CRY1 proteins. Three amounts (2, 10, 50 ng) of the Cry1 and Gm129 plasmid were used in 
the reporter gene assay. Experiments were done in triplicate and average values are plotted.   Error 
bars represent standard deviation of 3 biological repeats. Note: X-axis is not set to scale. 
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GM129 interacts with the CLOCK/BMAL1 complex on DNA both in vivo and in vitro 
 
    Although GM129 protein represses CLOCK-BMAL1’s activity in the reporter gene assay, the 
detailed molecular mechanism is unclear. Generally, a protein can function as a repressor by two 
mechanisms: (a) Repressor can bind to the activator complex on DNA and interfere its interaction 
with co-activator or with RNA polymerase II complex. (b) Repressor can directly dissociate the 
activator from DNA. Previously, we have reported that CRY1 binds to the CLOCK-BMAL1 
complex on DNA in vitro and in vivo (36). Here, we have conducted parallel experiments to 
examine how GM129 functions as a repressor of CLOCK:BMAL1. The in vivo system that we 
used employed an NIH3T3 cell line that stably expresses Flag-tagged GM129. A ChIP assay was 
conducted with these cells to measure the binding of GM129 to the E-box elements in the Per2, 
Dbp, Nr1d1 and Bmal1 promoters. As shown in Figure 2.4A, Flag-GM129 showed significant 
recruitment to the Per2, Dbp, and Nr1d1 E-box compared to the NIH3T3 controls. No significant 
recruitment was detected in the Bmal1 promoter that does not contain CLOCK:BMAL1 binding 
sites, which suggest the recruitment is specific and CLOCK:BMLA1 dependent.  Equally 
important, Flag tagged C1ORF51, a human homolog of Gm129, also interacts with hBMAL1 and 
binds to the hPer2 promoter in HEK293R cells that stably expresses Flag-C1ORF51 protein, 
which suggests that the molecular function of GM129 protein is evolutionarily conserved (Figures 
2.4B and 2.4C).  
    The in vivo interactions between GM129 and the Per2 promoter could be achieved either 
directly through the CLOCK:BMAL1 complex or through other proteins. Here, we used a defined 
in vitro system to elaborate on these protein-DNA interactions. The CLOCK:BMAL1 complex 
and Flag-GM129 were purified using anti-flag affinity chromatography and baculovirus 
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expression system as described previously (36). Purified GM129 is shown in Figure 2.4D. Then, 
we investigated the effects of GM129 on the CLOCK:BMAL1:E-box ternary complex using 
electromobility shift assay (EMSA). As shown in Figure 2.4E, CLOCK:BMAL1 binds to the E-
box specifically (lane 2), and addition of GM129 protein retards the mobility of the 
CLOCK:BMAL1:E-box complex indicating the binding of GM129 to the ternary complex (lanes 
3,4,5). CRY1 is a positive control that can also shift the CLOCK:BMAL1:E-box complex (lane 7) 
(36). GM129 on its own does not bind to E-box under the conditions used (lane 6), indicating that 
its binding to the ternary CLOCK:BMAL1:E-box complex through interaction with 
CLOCK:BMAL1.  
    Next, the interactions of GM129 with CLOCK:BMAL1:E-box was tested by an in vitro DNA 
pull-down assay to further confirm the conclusion from the EMSA experiments. In this assay, we 
used a 30-bp fragment encompassing a non-canonical E-box (CACGTT, Table 2.1) in the mouse 
Per2 promoter, which was shown to bind to CLOCK:BMAL1 complex (42,43). Purified GM129 
and other clock proteins were incubated with either wild-type or mutated E-box DNA immobilized 
on streptavidin-coupled magnetic beads. The beads were washed, and the DNA-bound proteins 
were analyzed by western blot as shown in Figure 2.4F. Clearly, GM129 binds strongly to the 
CLOCK:BMAL1 complex on wild-type E-box DNA substrate (lane 2) but not to mutated E-box 
(lane 3).  In agreement with previously published results (36), PER2 protein (negative control) 
does not bind to the CLOCK:BMAL1 complex on DNA (lane5). CRY1 (positive control) also 
showed strong interaction with the CLOCK:BMAL1:E-box (lane 8). Overall, these data 
unambiguously show that GM129 tightly binds to CLOCK:BMAL1 on E-box DNA. Together 
with the reporter gene assay, our biochemical analysis suggest that GM129 appears to repress 
transcription as a consequence of binding stably to the CLOCK:BMAL1:E-box complex. 
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Figure 2.4: GM129 binds to CLOCK/BMAL1 on DNA both in vitro and in vivo.  
(A) Flag-GM129 binding to E-box DNA sequence in the Per2, Dbp and Nr1d1 promoters was 
determined by ChIP assays followed by quantitative PCR. Crosslinked nuclear extracts were 
isolated from cells and subjected to ChIP assay with FLAG antibodies against Flag-GM129. 
NIH3T3 cells and Bmal1 promoter region primers were used as controls for immunoprecipitation 
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and PCR, respectively. Data are expressed as percentage of input. Error bars represent standard 
deviation of 3 experiments.  
(B) Interaction of human homolog of GM129 (C1ORF51) with endogenous hBMAL1 in extracts 
made from a 293R cell line stably expressing Flag-C1ORF51 under the control of a tetracycline 
inducible promoter (Flp-In/FLAG-C1ORF51 cells). FLAG resin was used to pull down Flag-
C1ORF51, and immunoprecipitates were analyzed by western blot. Note that Flag-C1ORF51 
protein is also enriched by flag resin without tetracycline due to the minor leaky expression.  
(C) C1ORF51 binding to the E-box DNA sequence in hPer2 promoter was determined by ChIP 
assays followed by quantitative PCR. Crosslinked nuclear extracts were isolated after 24 hours 
tetracycline induction and subjected to ChIP assay with FLAG antibodies against Flag-C1ORF51 
or IgG. Upon tetracycline treatment, Flag-C1ORF51 showed significant recruitment to the hPer2 
E-box compared to the IgG control and non-tetracycline controls (Left panel, black asterisk: 
p<0.05). No significant recruitment was detected in the hPer2 coding region (Right panel). Data 
are expressed as percentage of input. Error bars represent standard deviation of 3 experiments.  
(D) Flag-GM129 protein was expressed using the Sf21/baculovirus system. After affinity 
chromatography purification, protein was analyzed by SDS-PAGE/Commassie blue staining. 
GM129 protein is marked with asterisk confirmed by immunoblotting.  
(E) Effects of GM129 on the mobility of the CLOCK:BMAL1:E-box complex analyzed by 
electromobility shift assay (EMSA). A radiolabeled 14mer E-box duplex (1.5nM) (M34, Table 
2.1) (44) was incubated with purified BMAL1-CLOCK heterodimer (0.5nM), and then increasing 
amounts of GM129 proteins (0.1, 0.5, 1nM) were added. Note the addition of GM129 results in 
slower migration of the protein-DNA complex (lanes 3, 4 and 5). GM129 alone (1 nM) does not 
bind to DNA (lane 6). CRY1 (1 nM) was used as a positive control to show the shifted 
CLOCK:BMAL1:CRY1 complex on DNA. A dashed line parallel to the leading edge of the 
CLOCK:BMAL1:E-box complex is drawn to indicate the change in mobility of the protein-DNA 
bands upon addition of GM129 and CRY1.  
(F) GM129 binds to CLOCK:BMAL1:E-box determined by in vitro pull down assays. The 
CLOCK-BMAL1 complex (10 nM) was mixed with 10 nM GM129, PER2, or CRY1 protein, then 
500 ng immobilized 30-mer WT E-box or mutated E-box duplex DNA was added for an additional 
60 minutes incubation in binding buffer. Immobilized complexes were washed and then protein-
DNA complexes were eluted and analyzed by western blot. Proteins were detected by anti-CLOCK 
or anti-Flag (GM129, PER2, and CRY1) antibodies. 
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Gm129 gene deficiency affects the expression of clock-controlled genes 
 
    If GM129’s repressor function is essential and cannot be compensated by other genes, depletion 
of Gm129 in mice would affect circadian rhythm rhythmicity. To test this, Gm129tm1e(KOMP)Wtsi 
heterozygous mice (hereafter Gm129+/-) were obtained from the NIH Knockout Mouse Project 
(KOMP) Repository. The targeting strategy for the knockout is summarized in Figure 2.5A (45). 
Gm129-/- homozygous mice were obtained by mating these heterozygotes. Genotyping was done 
by PCR as shown in Figure 2.5B. Figures 2.5C and 2.5D show that Gm129 RNA and protein are 
not expressed in knock-out mice, thus the Gm129-/- is a null allele. Heterozygote intercrosses 
produced progeny of each genotype in the expected Mendelian frequency, indicating that 
homozygous animals are viable. Overall, homozygous Gm129-/- mice had no gross developmental 
abnormalities.  
    To determine the effects of GM129 disruption on behavioral rhythmicity, we monitored wheel-
running activity under constant darkness (DD) for 1 week, following an initial 14 days in a 12 hr 
light/ 12 hr dark (LD) cycle. Although the animals appear robustly rhythmic, we were not powered 
to detect minor period length differences (data not shown). The circadian oscillator controls not 
only behavior, but also gene transcription in the SCN and peripheral tissue. Hence, it was of 
interest to determine the effects of Gm129 deficiency on circadian regulation of gene transcription. 
Thus, we analyzed the expression pattern of canonical clock genes Dbp, Nr1d1,Per1 and Bmal1 
in mouse liver samples collected every 2 hours for 24 hours. In agreement with the behavioral 
analysis, the rhythmic expression of these clock genes retain in Gm129-/- mice compared to wild-
type (WT) mice (Figure 2.6A and 2.6B).  However, the peak of Dbp, Nr1d1 and Per1 gene 
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expression persists longer in Gm129-/- mouse liver between ZT10-ZT14. Bmal1 expression is also 
slightly altered at ZT16. These effects are likely caused by the absence of the GM129 
transcriptional repressor that exhibits a peak expression level at ZT12.  
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Figure 2.5: Generation of Gm129 knock-out mice 
(A) Schematic representation of the WT (Gm129+/+) allele and targeted allele (Gm129-/-). 
Homologous recombination leads to the insertion of a 7-kb LacZ and Neomycin cassette between 
exon 1 and exon 2 in the WT Gm129 allele.  Black lines represent introns. Black and dashed 
rectangles represent non-coding and coding exons, respectively. Solid line A and dashed line B 
locate the products of PCR genotyping. Two small arrows show the location of the primers used 
for RT-PCR (Table 2.1).  
(B) Primers were designed as indicated in Figure5A and Table 2.1 for genotyping. 984bp and 
662bp PCR products were amplified using WT, heterozygote or knock-out mouse tail genomic 
DNA, respectively.   
(C) Gm129 gene expression (normalized to Gapdh) in the WT mice and Gm129-/- mice. The value 
of Gm129 expression in Knock-out mice was set to 1. Error bars represent standard deviation of 3 
biological repeats.  
(D) GM129 protein deficiency in Gm129-/- mouse liver. Liver nuclear extracts were prepared from 
wild-type (Gm129+/+) or homozygous Gm129-/- mutant mice at ZT12 and analyzed by SDS-PAGE 
followed by immunoblotting. The GM129 signal is marked by a black asterisk. XPB is a loading 
control. 
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Lack of Gm129 in Cry1 knock-out mice delays the phase of Nr1d1 and Dbp expression 
    Because Gm129-/- mice do not show any significant alteration in their circadian rhythm, we 
suspect that GM129 functions in a redundant manner with another protein in mice. It was 
previously reported that, except for Bmal1 (9), deficiencies of single core clock regulator genes 
normally do not abolish circadian rhythms. For example, Cry1-/- and Cry2-/- single knock-out mice 
have stable circadian rhythms with altered period (8), but Cry-/- double knock-out mice are totally 
arrhythmic.  In addition, Per1 and Per2 genes also have redundant roles in circadian regulation 
(11,32). Therefore, we decided to combine the Gm129 mutation with another core clock gene 
mutation that possibly compensates GM129’s function. Although Gm129 does not have analogs 
in the mouse genome, our protein-protein interaction assay and reporter gene assay suggest Gm129 
gene has a functionally redundant role with Cryptochrome as a transcriptional repressor on 
CLOCK:BMAL1. Hence, we decided to make Cry1-/- Gm129-/- double knock-out mice to examine 
the role of Gm129 in circadian regulation. Dbp, Nr1d1, Per1 and Bmal1 rhythmic gene expression 
in liver were used as readouts of the circadian rhythm. Results are shown in Figure 2.6C and 
2.6D, which is aligned under and may be compared with Figure 2.6A and 2.6B. In agreement 
with a previous report, the Cry1 mutation alone causes an advanced phase shift (~ 4 hours) of Dbp 
(37), Per1 and Nr1d1 (black curve and blue curve). Most importantly, Cry-/-Gm129-/-mice exhibit 
robust, but significantly phase delayed Dbp and Nr1d1 circadian gene expression (about 2-4 hours 
phase shift) compared to Cry-/- mice (Figure 2.6C). Per1 gene expression exhibit a broader peak 
between ZT4-ZT10 compared to control (Figure 2.6D, left panel). These results are consistent 
with the finding in Gm129-/- mice, in which peak transcription of Dbp, Nr1d1 and Per1 persists 
longer than in WT mice between ZT12-ZT14. Equally important, rhythmic Bmal1 expression that 
is under the control of NR1D1 protein (3,10), is also affected by the Gm129 knock-out mutation 
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in Cry1-/- mice (Figure 2.6D, right panel). Thus, we reasoned that in WT mice, GM129’s phase 
modulator function is largely masked by CRY1 that is a more potent repressor than GM129. 
However, in the absence of CRY1, GM129 has a stronger role in regulating CLOCK:BMAL1 
activity. Thus, our genetic analyses suggest that Gm129 is a circadian clock modulator rather than 
an essential core component.  
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Figure 2.6: Effects of the disruption of Gm129 gene on circadian gene expression in mouse 
liver.  
(A and B) Circadian expression of Dbp, Nr1d1, Per1, and Bmal1 in wild-type (black curve) and 
Gm129-/- (Grey curve) mouse liver analyzed by quantitative RT-PCR.  
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(C and D) Circadian expression of Dbp, Nr1d1, Per1 and Bmal1 in Cry-/- (blue curve) and Cry-/-
Gm129-/- (red curve) mouse livers analyzed by quantitative RT-PCR.  
Liver samples were collected every 2 hours from mice that were housed under 12 hours light:12 
hour dark conditions. Dbp and Nr1d1 mRNA levels were first normalized to Gapdh expression. 
Then, the maximal value of gene expression in the day/night cycle was normalized to 1. Error bars 
represent standard deviation of two biological repeats. Red asterisk indicates significantly altered 
Dbp, Nr1d1, Per1, and Bmal1 transcription in Gm129-/- and Cry-/-Gm129-/- mouse liver compared 
to control (p<0.05). 
 
 
 
 
 
EXPERIMENTAL PROCEDURES  
 
Mice  
    All animal procedures were in accordance with the National Institutes of Health guidelines and 
were approved by the Institutional Animal Care and Use Committee of the University of North 
Carolina, Chapel Hill. Gm129 heterozygote mice were purchased from the UC Davis KOMP 
repository and bred to obtain Gm129-/- mice. Primers were designed as indicated (Figure 2.5A 
and Table 2.1) for genotyping.  Cry1-/-, Gm129-/- double knock-out mice were generated by 
crossing Cry1-/- (8) and Gm129-/- mice. All mice were maintained on a 12 hour light, 12 hour dark 
schedule. 
 
Plasmids 
    To generate pEGFPN1-Gm129, the Gm129 coding sequence was amplified by PCR from mouse 
fibroblast cDNA and inserted into the pEGFP-N1 vector. The pBABEpuro-Flag-HA-Gm129 
plasmid was generated by inserting Gm129 and Flag tag sequence into the pBABEpuro vector 
backbone. The pFast-Flag-Gm129-Myc construct was generated by inserting the Gm129 coding 
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sequence into the pFastbac1 (Invitrogen) vector with the Flag tag sequence at the forward oligo 
and Myc tag sequence at the reverse oligo. Constructs for expressing mCLOCK, mBMAL1, 
mCRY1, and mPER2 were described previously (36). 
 
Cell lines  
    NIH3T3 cells expressing Flag-GM129 were made by retrovirus infection. Briefly, the 
pBABEpuro-Flag-HA-Gm129 construct was co-transfected together with pVSVG and pCIHPZ 
into HEK293T to produce recombinant retrovirus particles. Then MEF cells were infected with 
the retrovirus and transfectants were selected in media containing puromycin for 2 weeks. Single 
colonies were picked and cultured for subsequent analysis. The Flp-In/FLAG-C1ORF51 cell line 
was generated according to the manufacturer's protocols using the Flp-In T-REx-293 system 
(Invitrogen). 
 
Immunoblotting and Antibodies 
    Both mouse liver lysates and liver nuclear extracts were prepared for Immunoblotting. To make 
mouse liver lysate, mouse liver samples were homogenized and lysed with lysis buffer (15mM 
HEPES pH 7.8, 250mM NaCl, 1% NP40, 10% Glycerol, protease inhibitor cocktail from Roche). 
Proteins from mouse liver nuclei were prepared according to the NUN procedure described 
previously (43). ANTI-FLAG antibody was purchased from Sigma-Aldrich. Anti-CLOCK, anti-
BMAL1 antibodies (Bethyl Lab), anti-mPER2 antibody (ADI) and anti-Gm129 (Santa Cruz 
Biotechnology) were used in the immunoblotting assays. Anti-mCRY antibody was produced in 
our laboratory (36). 
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Immunoprecipitation  
  Insect cells or mammalian cells were collected and lysed in lysis buffer (50 mM TrisCl pH 7.5, 
150mM NaCl, 10% Glycerol, 1%Tween-20, 0.1 % NP40, protease inhibitor cocktail from Roche). 
Lysates were incubated with anti-FLAG M2-agarose beads (Sigma) for 4 hours at 4 °C. Beads 
were washed 4 times with lysis buffer; bound proteins were eluted in 2X SDS-sample buffer and 
analyzed by immunoblotting. 
 
Fluorescence Microscopy 
  For GFP fluorescence microscopy, HEK293T cells were cultured on Poly-D-Lysine 12 mm 
coverslips (BD Biosciences) placed in 6-well plates. Cells were transfected with pEGFP-N1 and 
pEGFPN1-Gm129 plasmids using Lipofectamine 2000 reagent (Invitrogen) at around 50 % 
confluence. 48 hours after transfection, cells were washed twice with PBS, fixed immediately with 
3.7% methanol-free formaldehyde in PBS for 15 min, and washed twice with PBS. Coverslips 
were mounted with SlowFade Gold Antifade Reagent with DAPI (Invitrogen). Images were 
captures using a LeicaSP2 confocal microscope.  
    
Chromatin Immunoprecipitation (ChIP) and ChIP-Sequencing 
    Primers used in ChIP-PCR are given in Table 2.1. ChIP-PCR assays using cell nuclear extracts 
were conducted as described previously (36). For ChIP-PCR and ChIP-Seq using mouse tissues, 
liver chromatin was prepared according to a previously published protocol (46) with minor 
modification. Briefly, livers from mice were immediately homogenized and cross-linked in PBS 
buffer including 1% formaldehyde (5 ml per liver), and the homogenate was incubated for 15 min 
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at 25 °C. Cross-linking reactions were stopped by the addition of 21 ml of ice-cold nuclei buffer 
(2.2 M sucrose, 125 mM glycine, 10 mM HEPES pH 7.6, 15 mM KCl, 2 mM EDTA, 0.15 mM 
spermine, 0.5 mM spermidine, 0.5 mM DTT, 0.5 mM PMSF and 10% glycerol). The homogenate 
was layered on top of 10 ml of cold nuclei buffer and centrifuged for 90 min at 24,000 rpm 
(100,000g) at 4 °C in a Beckmann SW27 rotor. The nuclei were washed with wash buffer (20 mM 
Tris, pH 7.5, 150 mM NaCl, 2 mM EDTA) and stored at    -80 °C. Cross-linked nuclei were then 
subjected to ChIP analysis according the procedures described previously (36). For ChIP-seq, 
ChIP DNA was ligated to single-end sequencing adapters and amplified. DNA fragments of 300-
800 bp in size were purified and sequenced (50 base) on an Illumina Hi-seq2000 instrument 
(Illumina, California, USA). The reads were aligned to the mm9 mouse reference genome using 
Bowtie accepting up to 4 reportable alignments and two mismatches per read (47). In cases where 
more than a single alignment was possible, only the one with the highest mapping quality was 
reported using bowtie’s "--best" option. To generate ChIP-seq signal tracks, reads were extended 
in-silico to 150bp, and the number of reads overlapping with each base in the genome was counted 
and divided by the chromosome-wide average of per-base read coverage. The average signal over 
50bp windows was calculated and viewed using the UCSC genome browser (Figure 2.1).  
 
Reporter gene assay 
    Firefly luciferase was used as a reporter that is controlled by the mPer1 promoter sequence (48). 
Renilla luciferase was used as a transfection control.  HEK 293T cells were co-transfected with 
indicated amounts of plasmids using Lipofectamine® 2000 (Invitrogen). 36 hours post 
transfection, cells were collected, and luciferase activities were assayed using Dual-Luciferase® 
Reporter Assay System according to the manufacturer's protocols (Promogea). 
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Pulldown Assay with Immobilized DNA 
    Biotin labeled E-box DNA or mutated E-box DNA (Table 2.1) was immobilized on magnetic 
streptavidin beads. Immobilized DNA was washed twice in reaction buffer (10 mm Tris-HCl, pH 
7.9, 50 mm NaCl, 5 mM dithiothreitol, 10% glycerol, 0.01% Nonidet P-40 and 10 μg/ml BSA) 
before setting up binding reactions. Reactions (200μl) were prepared in reaction buffer with the 
indicated combinations of CLOCK:BMAL1 (10 nM), GM129 (10 nM), PER2 (10 nM), and CRY1 
(10 nM) and 500 ng of immobilized DNA. After incubation for 1 h at 4°C, DNA-protein complexes 
were collected on a magnet and washed three times with reaction buffer. The proteins associating 
with the DNA were analyzed by SDS-PAGE and immunoblotting.  
 
RNA Extraction, Reverse Transcription and Quantitative Real-time RT-PCR 
    Mice of each genotype housed in LD12:12 were sacrificed every 2 hours starting from ZT 0 and 
livers were collected, washed with PBS and immediately frozen in dry ice and stored in -80 ºC 
until further use. RNA samples were prepared by TRIzol reagent (Invitrogen) and RNAeasy 
(Qiagen).  Total RNA (500 ng) was reverse transcribed with oligo(dT)20 using SuperScript III 
(Invitrogen) according to the manufacturer's instructions. Quantitative Real-time PCR assays were 
performed by using an ABI 7300 System (Applied Biosystems) and MaximaTM SYBR 
Green/ROX qPCR Master Mix (Fermentas) was used. Primers are listed in Table 2.1.  
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Table 2.1 
 
Primer sets used for ChIP assay. 
Name Sequence Reference 
mPer2E2F GGTTCCGCCCCGCCAGTATGC Yoo SH et al. PNAS(2005) 
mPer2E2R CCGTCACTTGGTGCGCTCGGC   
mDbp5F TGTGAACACTCGGCTCCTTT  This study 
mDbp5R ATATTTGGCCAATGGGAGGA   
mNr1d1CPF GCTGCTGGAAAAGTGTGTCA  This study 
mNr1d1CPR ATGGAGAAATGAGGCACCAG   
mBmal50F CGGATTGGTCGGAAAGTAGG  This study 
mBmal50R AGCCATGCCGACACTCAC   
hPer2CPF ATTGAGGAACCGACGAGGT  This study 
hPer2CPR GCCCACAGCTGCACGTAT   
Gm129CPF CACGGCTGGAGTGTACAGAG      This study 
Gm129CPR GAAAGAGTGGGGAGTCACGA      
 
Primer sets used for Genotyping. 
Name Sequence Reference 
CSD-Gm129-
TTR1  CAGAACCTGCAACTGAAAAGCAAAGC  
Common-3’F CACACCTCCCCCTGAACCTGAAA This study 
Gm129FG5    GCA GTG CTG TCC TAT TTA AGG CTA TGA  
 
 
Primer sets used for RT-PCR. 
 
Oligo sets used for EMSA and DNA pulldown assay. 
Name Sequence Reference 
M34TOP GGGACACGTGACCC 
Hogenesch et al. 
PNAS(1998) M34BTM GGGTCACGTGTCCC 
E-box AGCGCGCGCGGTCACGTTTTCCACTATGTG Yoo et al.  
Mutated E-box AGCGCGCGCGGTGCTAGTTTCCACTATGTG PNAS(2005) 
 
 
Gene Name Forward primer (5’-3’) Reverse Primer (5’-3’) 
Gm129 ACTCAAGATGGGTCGCTTTG GGGCAGCTATGTGAGGAAAC 
mGapdh AACTTTGGCATTGTGGAAGG ACACATTGGGGGTAGGAACA 
mDbp GACACCGTGGAGGTGCTAAT     ACCTCCGGCTCCAGTACTTC     
mNr1d1 CCTGACTCAAGGTTGTCCCACAT CATGGCCACTTGTAGACTTCCTG 
mPer1 TGAGGAGCCAGAGAGGAAAG GGCTGAAGAGGCAGTGTAGG 
mBmal1 TCATTGATGCCAAGACTGGA CAAATAGCCTGTGCTGTGGA 
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DISCUSSION 
 
    In the circadian TTFL model, CRY and PER transcriptional repressors are essential components 
of the feedback loop. Besides CRY and PER, there are additional non-essential components of the 
core clock machinery that can repress CLOCK:BMAL1 activity. These proteins include the helix-
loop-helix transcription factors, such as Differentially-Expressed in Chondorocytes-1 and -2 
(DEC1 and DEC2) and Inhibitor of DNA Binding 2 (ID2). These proteins can inhibit 
CLOCK:BMAL1 activities possibly by interfering with the formation of the CLOCK:BMAL1 
complex (49-51). DEC1 protein was also reported to delay the phases of Per1, Dbp and Nr1d1 in 
cells after serum synchronization (52). Another non-essential repressor is CLOCK-Interacting 
Protein, Circadian (CIPC), which can interact with CLOCK and inhibits CLOCK-BMAL1 
transcriptional activity presumably by disrupting the binding between CLOCK and its 
transcriptional coactivators (53). Here, we demonstrated that similar to Cryptochrome, GM129 is 
a novel transcriptional repressor of CLOCK:BMAL1 protein complex that interacts with 
CLOCK:BMAL1 on DNA. 
    It was surprising to find that the effect of GM129 on CLOCK:BMAL1 activity in the reporter 
gene assay is almost as strong as CRY1, and that the mechanism of GM129 is similar to that of 
the CRYs in that it binds to CLOCK:BMAL1:E-box complexes. However, important differences 
must exist between the function of CRYs and GM129 since GM129 is unable to compensate for 
the absence of Crys in Cry1-/-Cry2-/- double knock-out mice, which are arrhythmic (8). Our results 
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also suggest that, unlike CRY1, GM129 is an non-essential CLOCK:BMAL1 repressor that is not 
required for circadian rhythm generation, but functions as a modulator to influence the phase of 
CLOCK:BMAL1 controlled transcriptional oscillation. We noticed that, in addition to BMAL1, 
GM129 also interacts with PER2 in our immunoprecipitation assays. Further investigation on these 
protein-protein interactions might help us to understand the differences between GM129 and 
Cryptochromes. It is also conceivable that Gm129 might be essential for the function of some 
peripheral clocks when isolated cells are analyzed. 
    Our finding of Gm129 was driven by the hypothesis that mining ChIP-seq data for genes with 
high affinity CLOCK:BMAL1 binding sites in their promoter will identify important factors in the 
circadian clock regulation. In addition to Gm129, other genes also contains high affinity 
CLOCK:BMAL1 binding sites in their promoter region with uncharacterized functions in 
circadian physiology. Investigations on these genes could introduce more new players in molecular 
clock regulation.  
    Gm129 may also contribute to non-clock pathways in addition to its function in the core clock 
machinery.  Many circadian transcriptional regulators have roles in multiple pathways. It was 
previously reported that both PER and CRY can directly interact with nuclear receptors to 
influence related signaling pathways (54-56). Thus, in order to understand the function of GM129 
protein in circadian physiology, it will be important to identify the GM129’s binding partners and 
map its genome-wide binding sites in future studies.  
    In conclusion, our findings indicate a physiological role for Gm129 in the transcriptional 
regulation of clock-controlled genes. GM129 protein levels show very strong oscillation with a 
Peak at CT12, 8 hours earlier than the peak of PER and CRY transcriptional repressors (peak 
CT20-CT24) (Figure 2.2B). Thus, GM129 protein can repress CLOCK:BMAL1 activity in a 
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different time window compared to CRY and PER (Figure 2.7). Together with other essential and 
non-essential CLOCK:BMAL1 repressors, GM129 contributes to the precision of the molecular 
clock and fine-tunes regulation of rhythmic gene expression.  
 
 
 
  
Figure 2.7: Model for the role of GM129 in modulating CLOCK:BMAL1 activities 
Both GM129 and Cryptochromes could repress transcriptional activator CLOCK:BMAL by 
similar mechanisms but at different times. Cryptochromes reach their peak protein expression 
levels at ZT20-24, and GM129 protein has peak expression at ZT12. Thus, GM129 and CRYs 
regulate the molecular clock in two separate time windows. 
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         ENDNOTES 
 
1Chapter 2 was published as: Annayev Y, Adar S, Chiou YY, Lieb JD, Sancar A, Ye R. (2014) 
Gene model 129 (Gm129) encodes a novel transcriptional repressor that modulates circadian gene 
expression. J Biol Chem. 289(8):5013-24. 
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CHAPTER 3: CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
      Daily rhythms in organismal behavioral, physiological, and metabolic events are controlled by 
circadian clock. Key components of the core clock components have been identified and it was 
shown that mutations in those genes have been implicated in sleep and metabolic disorders (23,24).  
There are also several non-essential clock genes that can influence circadian transcription but their 
deficiency does not have a major effect on the daily behavioral rhythms of mice (50-53).  Here, I 
describe a novel gene called Gm129 and show that it also modulates circadian transcription and 
functions as a repressor.  
   Biochemical and cellular assays show that GM129 is a nuclear protein, and it interacts with 
BMAL1 and PER2. Also, in the reporter gene assay it represses CLOCK/BMAL1 induced 
transcription of luciferase gene. Even though, Gm129 knock-out mice (Gm129-/-) don’t show 
significant change in the circadian expression of clock genes, Cry1 and Gm129 double knock-out 
mice show about 4-6 hr phase advance in the circadian oscillation of clock genes analyzed 
indicating that Gm129 functions in the regulation of the circadian clock. However, there is still a 
lot of unknowns remain regarding the physiological role of Gm129.  
  We found that GM129 interacts with BMAL1 and PER2. It is reasonable to think that the GM129 
interaction with BMAL1 is required for its repressor function since my in vitro data suggest that it 
binds to E-box DNA fragment only when CLOCK/BMAL1 complex is present in the reaction. On 
the other hand, the importance of the interaction with PER2 is unknown.  In HEK-293T cells 
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recombinant GM129 is heavily phosphorylated when co-expressed with either BMAL1 or PER2 
(data not shown) indicating an effect of PER2 interaction on GM129. Also, PER2 protein levels 
peak about 10 hours later compared to the peak of the GM129 protein which presents another 
challenge to understanding the significance of this interaction. Our analysis was mainly done in 
liver where PER2 and GM129 protein levels peak at the different times.  Possible explanation 
maybe that the interaction of GM129 with PER2 may be important in some tissues where both 
proteins peak at around same time. Also, it is not necessary to have both proteins to peak at the 
same time, having enough of each proteins at some point in the circadian cycle so that they can 
function together maybe sufficient. GM129 and PER2 may function as repressors in small time 
frame before another repressor replaces either GM129 or PER2 (Figure 3.1).  It is also possible 
that, these two proteins affect each other’s stability and therefore regulate each other.  
 
Figure 3.1: Possible importance of GM129 and PER2 complex. 
GM129 and PER2 proteins peak at different time points. These proteins may form a complex for 
a short time period before other repressors take over. Gray areas under the plots represent those 
time points where they maybe small amounts of each protein.   
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 An additional subject of investigation would be to identify other DNA sequences GM129 binds 
in the genome in addition to E-box enhancer elements. The fact that GM129 does not bind to 
BMAL1 promoter excludes the possibility of it binding to RORE (ROR response elements).  
However, it is still possible that GM129 can bind to the D-boxes. It is also possible that GM129 
could bind to the promoters of certain group of genes not tested in our study and regulate specific 
pathways. Understanding of GM129 binding sites on the genome may provide wealth of evidence 
on its specific function in the regulation of the circadian clock and mammalian physiology.  
   Currently, we know that GM129 interacts with BMAL1 and PER2 but it is also possible that 
GM129 can interacts with other proteins. Specifically, it is not clear how GM129 represses 
CLOCK/BMAL1 controlled transcription. There may be other factors that function in transcription 
repression or another clock gene may be involved in that process.  
    Finally, Gm129-KO mice were not analyzed for any metabolic or physiological defects in this 
study. As stated in chapter 1, mutations in core clock genes results in metabolic and sleep disorders 
(23,24). Gm129-KO mice feed and breed well and did not have a distinct abnormal physical 
appearance. However, it would be interesting to study Gm129-KO mice for any abnormalities in 
metabolic, sleep or other physiological pathways. Moreover, Cry1/Gm129 double knock-out mice 
also could be analyzed to better define the function of Gm129 because we see a more dramatic 
effect in circadian gene expression in this double knock-out compared to the single knock-out 
mice.  
   Recently, two separate groups published their studies on Gm129 (57,58).  Both studies are in 
agreement with our findings. One of them discovered Gm129, similar to our discovery, by doing 
ChIP-seq on BMAL1 binding sites (58). In addition to GM129 interaction to BMAL1 and PER2 
they also show that GM129 interacts with DEC2 and CRY2. They also show that repressor activity 
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of GM129 is dependent on histone deacetylases (HDACs). Repressor activity of GM129 was 
reversed when they treated the cells with HDAC inhibitor trichostatin A (TSA), an inhibitor of 
HDAC activity. In addition to interactions with the core clock proteins they show that GM129 
interacts with HDAC1 and they conclude that GM129 mediated repression is HDAC dependent. 
They also analyzed GM129-KO mice and found that GM129-KO mice show a slight change in 
the period length. Similar to our study, they crossed GM129-KO mice with Cry1-KO mice to 
analyze wheel running activities. They were reasoning that Gm129 gene shows Cry2 gene like 
properties with respect to its interactions and effect on wheel running activities of mice. However, 
unlike Cry -/- double knockout mice, Cry1-/- Gm129-/- double knock-out mice weren’t arrhythmic 
and had a 0.1hr difference compared to Cry1 -/- mice (58).   The other group used computational 
tools to discover Gm129.  They used machine learning to analyze and identify genes that resemble 
core clock genes from the genome-scale datasets. They tested the interaction of top candidate genes 
with the core clock proteins and found that GM129, similar to our finding, interacts with BMAL1 
and PER2.  They also show that GM129 abrogates BMAL1 interaction with the CBP and represses 
CLOCK/BMAL1 induced transcription (57). Overall, both studies show that GM129 is core clock 
gene and repress circadian transcription by several mechanisms.  
   In conclusion, I show that Gm129 is clock gene with repressor function and it interacts with the 
core clock genes. Gm129-KO mice show altered expression of clock genes and this effect is more 
dramatic when the Gm129 mutation is combined with Cry1 mutation. In addition, there are still 
some unanswered questions on the function of Gm129 regarding its binding sites in the genome, 
its interacting proteins and the phenotype of Gm129-KO mice.  
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